Charles River Laboratories International Inc. (CRL)
CRL · Health Care · 
United States
Charles River Laboratories International Inc. (CRL) is a US company in the Health Care sector. The stock has its largest weight in XDEW (S&P 500 Equal Weight), at 0.26%. Anyone who holds an ETF containing Charles River Laboratories International also has an indirect stake in the company.
Data and Charts: Charles River Laboratories International
Key Data for Charles River Laboratories International
Charles River Laboratories International Stock Price Chart
The Charles River Laboratories International chart shows daily closing prices and is set to the current year by default. The stock is up 80.2% year to date and up 100.7% over twelve months. The last recorded close on October 30, 2026, was $359.41, at 93% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
Charles River Laboratories International Stock Performance
| Year to date | +80.2% | 1 year | +100.7% |
|---|---|---|---|
| 1 month | +21.8% | 3 months | +54.6% |
| Calendar year 2025 | +8.1% |
Measured in euros, Charles River Laboratories International is up 89.5% year to date and up 107.5% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Charles River Laboratories International
What ETF Is Charles River Laboratories International In?
Charles River Laboratories International has average ETF coverage and is held by 11 of the 104 ETFs we track, which together follow 5 indices. That puts the stock in more ETFs than 66.9% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XDEW | S&P 500 Equal Weight | 0.26% | €2.63 |
| ZPRS / WDSD | MSCI World Small Cap | 0.18% | €1.76 |
| XSWC / XSWD | MSCI World Small Cap | 0.17% | €1.72 |
| SXR8 | S&P 500 | 0.03% | €0.30 |
| SPYL / SPY5 | S&P 500 | 0.03% | €0.29 |
| WIMI | MSCI World IMI | 0.02% | €0.16 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Charles River Laboratories International, based on each fund's latest holdings list.
US-listed ETFs holding Charles River Laboratories International (weight per latest SEC filing): IVV 0.02%, SPY 0.02%, VOO 0.02%, VTI 0.02%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Charles River Laboratories International Weight in iShares Core S&P 500 (SXR8) Since 2021
In iShares Core S&P 500 (SXR8), Charles River Laboratories International had a weight of 0.05% on Jun 30, 2021 and 0.03% on Oct 30, 2026. The fund tracks the S&P 500. Its share peaked at 0.06% on Sep 30, 2021. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Charles River Laboratories International overlaps with the rest of a portfolio.
What Charles River Laboratories International Executives and Directors Traded Recently
| Date | Person | Type | Shares | Price |
|---|---|---|---|---|
| Oct 22, 2026 | FOSTER JAMES C Director | Sell (plan) | 24,042 | $350.00 |
| Oct 21, 2026 | Parisotto Shannon M Officer, CEVP, Disc & Safety Assessment | Sell (plan) | 2,156 | $344.41 |
| Oct 5, 2026 | Parisotto Shannon M Officer, CEVP, Disc & Safety Assessment | Sell (plan) | 981 | $308.44 |
| Sep 30, 2026 | Coleman Glenn Officer, EVP & Chief Financial Officer | Buy | 10 | $297.43 |
The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded.
“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32.
Stocks With ETF Exposure Similar to Charles River Laboratories International
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Charles River Laboratories International | – | – | +100.7% | 49.3% | -3.6% | -0.9% |
| Align Technology | 11 | – | +8.3% | 45.9% | 10.2% | +0.9% |
| Baxter International | 11 | – | +20.0% | 40.8% | -8.5% | +5.7% |
| DaVita | 11 | -0.35 | +57.9% | 38.9% | 5.5% | +6.5% |
| Henry Schein | 11 | – | +34.9% | 26.4% | 3.0% | +4.0% |
| Insulet Corporation | 11 | – | -52.0% | 40.8% | 9.1% | +30.7% |
| Revvity | 11 | +0.54 | +72.5% | 37.1% | 8.4% | +3.7% |
| Solventum Corporation | 11 | – | +17.4% | 29.8% | 18.7% | +0.9% |
| Bio-Techne Corporation | 11 | – | +19.2% | 42.5% | 15.0% | -0.4% |
These stocks reach a portfolio through largely the same funds as Charles River Laboratories International. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Charles River Laboratories International
Charles River Laboratories International Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 27, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 4.1 | 0.5 | 11.5% |
| FY ended Dec 2024 | 4.0 | 0.0 | 0.5% |
| FY ended Dec 2025 | 4.0 | -0.1 | -3.6% |
Technical Analysis: Charles River Laboratories International
Charles River Laboratories International Risk Metrics
The close on Oct 30, 2026, was 4.4% below the highest close since Aug 12, 2024. That high was reached on Oct 29, 2026. When the S&P 500 rose or fell 1%, Charles River Laboratories International moved 1.31% on average in the same direction (past 252 trading days). The correlation of 0.36, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Charles River Laboratories International.
What Charles River Laboratories International Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| Waters Corporation | +0.66 | |
| Agilent Technologies Inc. | +0.61 | |
| IQVIA Holdings Inc | +0.60 | |
| Thermo Fisher Scientific Inc. | +0.58 | |
| Illumina Inc. | +0.54 | |
| Revvity Inc. | +0.54 | |
| DaVita Inc. | -0.35 | |
| SAPIEN | -0.31 | |
| YB | -0.28 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
